approval
saveMS CONTIN (MORPHINE SULFATE) — FDA approval
community read0 votes
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025 · 282d ago
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025 · 282d ago
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025 · 282d ago
- approvalDURAMORPH PF (MORPHINE SULFATE) — FDA approvalDec 22, 2025 · 282d ago
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025 · 282d ago
- approvalMORPHINE SULFATE — FDA approvalDec 22, 2025 · 282d ago
- approvalDURAMORPH PF (MORPHINE SULFATE) — FDA approvalDec 22, 2025 · 282d ago
- approvalMS CONTIN (MORPHINE SULFATE) — FDA approvalDec 22, 2025 · 282d ago
🐶 often sniffed alongside
top 8- tagApproval428 co-mentions · 214 sources
- drugMS CONTIN261 co-mentions · 221 sources
- drugDURAMORPH PF245 co-mentions · 221 sources
- drugInfumorph245 co-mentions · 221 sources
- drugmorphine sulfate ER221 co-mentions · 221 sources
- drugMorphine Sulfate Pfizer221 co-mentions · 221 sources
- drugmorphine sulfate SR221 co-mentions · 221 sources
- drugMorphine Sulfate Mallinckrodt221 co-mentions · 221 sources
comments(0)
5-min edit window · permanent after that